Safety evaluation of excessive intake of the tablet containing "Lactotripeptide (VPP, IPP)" in subjects with normal blood pressure to mild hypertension

Japanese Pharmacology and Therapeutics

Volumn 34, Issue 10, 2006, Pages 1107-1117

  Ishida, Yu ^a   Aihara, Kotaro ^a   Sagitani, Atsuhiro ^a   Kaneko, Kyoko ^a   Mizutani, Jun ^a   Nakamura, Yasunori ^a   Nakamura, Kayo ^b   Shimura, Tokuro ^b   Yagasaki, Kisaburou ^c  

^a CALPIS Co Ltd   (Japan)

^b Japan Medical Research Service Co Ltd   (Japan)

^c Sakurakai Hospital   (Japan)

Author keywords

Excessive intake; Lactotripeptide; Safety test

Indexed keywords

ISOLEUCYLPROPYLPROLINE; LACTOTRIPEPTIDE; PLACEBO; POLYPEPTIDE; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VALYLPROPYLPROLINE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; LACTOBACILLUS HELVETICUS; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE; TABLET; URINALYSIS;

EID: 56149098152     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 1995; 78: 777-83.
2. Yamamoto N, Akino A, Takano T. Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci Biotech Biochem 1994; 58: 776-8.
3. Nakamura Y, Yamamoto N, Sakai K, Takano T. Antihypertensive effects of sour milk and peptides isolated from that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 1995; 78: 1253-7.
4. Nakamura Y, Masuda O, Takano T. Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotech Biochem 1996; 60: 488-9.
5. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996; 126: 3063-7.
6. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effects of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767-71.
7. Japanese source.
8. Japanese source.
9. Japanese source.
10. Japanese source.
11. Ueno K, Mizuno S, Yamamoto N. Purification and characterization of an endopeptidase that has an important role in the carboxyl terminal processing of antihypertensive peptides in Lactobacillus helveticus CM4. Letters in Applied Microbiology 2004; 39: 313-8.
12. Mizuno S, Nishimura S, Matsuura K, Gotou T, Yamamoto N. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J Dairy Sci 2004; 87: 3183-8.
13. Matsuura K, Mizuno S, Nishimura S, Gotou T, Yamamoto N. Quantitative analysis of antihypertensive peptides, Val-Pro-Pro and Ile-Pro-Pro, in casein hydrolyzate with Aspergillus oryzae protease by a LC-MS method. Milchwissenschaft 2005; 60 (1): 24-7.
14. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M, et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 2005; 94 (1): 84-91.
15. Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O, et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Medicinal Food 2005; 8 (4): 423-30.
16. Japanese source.
17. Kawasaki T, Itoh K, Uezono K, Sasaki H. Estimation of 24-hour urinary sodium and potassium excretion from predicted value of 24-hour urinary creatinine excretion and fractional urine sodium/creatinine and potassium/creatinine ratio. Seventh Symposium on Salt II 1993; 257-62.